PodParley PodParley
PodParley
Clinical and Financial Risk? Anyone? Anyone? episode artwork

EPISODE · Dec 15, 2022 · 21 MIN

Clinical and Financial Risk? Anyone? Anyone?

from 4sight Health Roundup (for Healthcare Executives) · host 4sight Health Roundup

Value-based reimbursement has the potential to lower costs and improve outcomes. But providers don't seem to be that into it, at least not now. We talked about why and what has to change on the new episode of the 4sight Health Roundup podcast. Sponsored by Infor.  David Johnson is CEO of 4sight Health. Julie Vaughan Murchinson is Partner of Transformation Capital and former CEO of Health Evolution. David Burda is News Editor and Columnist of 4sight Health.

Episode metadata supplied by the publisher feed · Published Dec 15, 2022

Embed this episode

NOW PLAYING

Clinical and Financial Risk? Anyone? Anyone?

0:00 21:47

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of 4sight Health Roundup (for Healthcare Executives)?

This episode is 21 minutes long.

When was this 4sight Health Roundup (for Healthcare Executives) episode published?

This episode was published on December 15, 2022.

Can I download this 4sight Health Roundup (for Healthcare Executives) episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!